Related Experiment Videos

Transposition of gentamicin resistance to staphylococcal plasmids encoding resistance to cationic agents

Insights

Researchers demonstrated that a chromosomal gentamicin resistance gene can integrate into the pWG115 plasmid in methicillin-resistant Staphylococcus aureus. This integration creates a new plasmid, Tn3851, which confers resistance to multiple antibiotics.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant public health threat.
  • Antibiotic resistance in MRSA is often mediated by plasmids and transposons.
  • Plasmid pWG115 confers resistance to trimethoprim and cationic surface-active agents.

Purpose of the Study:

  • To investigate the relationship between pWG115 and gentamicin resistance plasmids.
  • To determine if chromosomal gentamicin resistance determinants can transpose into pWG115.
  • To characterize the resulting plasmid and its antibiotic resistance profile.

Main Methods:

  • Mixed-culture transfer experiments using selective agents.
  • EcoR1 restriction enzyme analysis of plasmids.
  • Phenotypic characterization of antibiotic resistance.

Main Results:

  • Chromosomal gentamicin resistance determinant successfully transposed into pWG115.
  • An 18.0 megadalton plasmid, phenotypically identical to naturally occurring gentamicin resistance plasmids, was generated.
  • EcoR1 analysis revealed transposition into at least two sites on pWG115, with one site matching pWG53.
  • The transposed element, designated Tn3851, confers resistance to gentamicin, tobramycin, and kanamycin.

Conclusions:

  • The chromosomal gentamicin resistance determinant can transpose into pWG115, forming a novel plasmid.
  • This transposition mechanism contributes to the dissemination of antibiotic resistance in MRSA.
  • The identified transposon, Tn3851, is a significant factor in multi-drug resistance in Staphylococcus aureus.

Related Concept Videos